SARS-CoV-2 T-cell response in COVID-19 convalescent patients with and without lung sequelae

Cruz, TamaraMendoza Barco, NúriaPerea, LídiaAlbacar Riobóo, NúriaGonzález, AzucenaHernández-González, FernandaJuan, ManelAgustí García-Navarro, ÀlvarSellarés Torres, JacoboSibila Vidal, OriolFaner, Rosa2023-05-292023-05-292022-03-072312-0541https://hdl.handle.net/2445/198563A specific T-cell response persists in the majority of COVID-19 patients 6 months after hospital discharge. This response is more prominent in those who required critical care during the acute COVID-19 episode but is reduced in patients with lung sequelae.4 p.application/pdfengcc-by-nc (c) Cruz, Tamara et al., 2022https://creativecommons.org/licenses/by-nc/4.0/SARS-CoV-2PneumòniaPulmóCèl·lules TSARS-CoV-2PneumoniaLungT cellsSARS-CoV-2 T-cell response in COVID-19 convalescent patients with and without lung sequelaeinfo:eu-repo/semantics/article7248392023-05-29info:eu-repo/semantics/openAccess930050835261913